Guided by rigorous analytical standards and effective tactical execution, we transform China's clinical potential into global success.
Our Mission is to provide global clients with innovative perspectives by leveraging our deep-rooted expertise in the China clinical landscape. Empowered by a full range of clinical trial consulting, design, conduction, management, reporting and analysis services, we are dedicated to helping our clients to achieve effective and successful research goals.
Serving scientists and researchers across the globe with comprehensive clinical research capabilities.
We are specialized in comprehensive bioanalytical testing services to advance your drug development, including biomarker ...
Read MoreAs a highly flexible, fit-for-purpose clinical development CRO, Protheragen offers full-service clinical pharmacology supports ...
Read MoreOur clinical team is committed to ensuring the participants safety before initiating each FIH study. We offer stringent participant ...
Read MoreWith advanced clinical operation facilities and highly experienced statistician and clinical team, we are confident in completing your ...
Read MoreWith a global network of therapeutic experts, Protheragen is dedicated to providing expert CRO services for your early clinical trials.
Read MoreOur integrated approach will ensure generating accurate data for phase IIa outcomes. We are dedicated to working ...
Read MoreAs a global leading clinical trial CRO, Protheragen offers end-to-end phase IIb-III clinical trial services from the start ...
Read MoreTo help our clients achieve more regulatory success for approved drugs, Protheragen offers comprehensive suite of phase ...
Read MoreWe partner with our clients to provide high-quality, reliable, accurate, and statistically sound data for clinical trials ...
Read MoreFrom dual-country operations to specialized therapeutic expertise, we bring capabilities that accelerate your clinical development.
Dual-country clinical trial capabilities leveraging China's vast patient base and Australia's R&D tax incentives for cost-effective, globally accepted data.
Extensive experience with Investigator-Initiated Trials across China — navigating regulatory pathways, site activation, and real-world data generation with speed.
Access to diverse, treatment-naive patient populations across China's top-tier hospitals. Fast site activation — from contract to first patient in weeks, not months.
Deep specialization in advanced therapies including CAR-T, gene editing, and stem cell trials. Dedicated expertise in CMC, potency assays, and long-term follow-up protocols.